Literature DB >> 18951857

Bilayered chitosan-based scaffolds for osteochondral tissue engineering: influence of hydroxyapatite on in vitro cytotoxicity and dynamic bioactivity studies in a specific double-chamber bioreactor.

Patrícia B Malafaya1, Rui L Reis.   

Abstract

Osteochondral tissue engineering presents a current research challenge due to the necessity of combining both bone and cartilage tissue engineering principles. In the present study, bilayered chitosan-based scaffolds are developed based on the optimization of both polymeric and composite scaffolds. A particle aggregation methodology is proposed in order to achieve an improved integrative bone-cartilage interface needed for this application, since any discontinuity is likely to cause long-term device failure. Cytotoxicity was evaluated by the MTS assay with the L929 fibroblast cell line for different conditions. Surprisingly, in composite scaffolds using unsintered hydroxyapatite, cytotoxicity was observed in vitro. This work reports the investigation that was conducted to overcome and explain this behaviour. It is suggest that the uptake of divalent cations may induce the cytotoxic behaviour. Sintered hydroxyapatite was consequently used and showed no cytotoxicity when compared to the controls. Microcomputed tomography (micro-CT) was carried out to accurately quantify porosity, interconnectivity, ceramic content, particle and pore sizes. The results showed that the developed scaffolds are highly interconnected and present the ideal pore size range to be morphometrically suitable for the proposed applications. Dynamical mechanical analysis (DMA) demonstrated that the scaffolds are mechanically stable in the wet state even under dynamic compression. The obtained elastic modulus was, respectively, 4.21+/-1.04, 7.98+/-1.77 and 6.26+/-1.04 MPa at 1 Hz frequency for polymeric, composite and bilayered scaffolds. Bioactivity studies using both a simulated body fluid (SBF) and a simulated synovial fluid (SSF) were conducted in order to assure that the polymeric component for chondrogenic part would not mineralize, as confirmed by scanning electron microscopy (SEM), inductively coupled plasma-optical emission spectroscopy (ICP) and energy-dispersive spectroscopy (EDS) for different immersion periods. The assays were carried out also under dynamic conditions using, for this purpose, a specifically designed double-chamber bioreactor, aiming at a future osteochondral application. It was concluded that chitosan-based bilayered scaffolds produced by particle aggregation overcome any risk of delamination of both polymeric and composite parts designed, respectively, for chondrogenic and osteogenic components that are mechanically stable. Moreover, the proposed bilayered scaffolds could serve as alternative, biocompatible and safe biodegradable scaffolds for osteochondral tissue engineering applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951857     DOI: 10.1016/j.actbio.2008.09.017

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  17 in total

1.  Human umbilical cord mesenchymal stromal cells in a sandwich approach for osteochondral tissue engineering.

Authors:  Limin Wang; Liang Zhao; Michael S Detamore
Journal:  J Tissue Eng Regen Med       Date:  2010-12-30       Impact factor: 3.963

2.  Selective laser sintering scaffold with hierarchical architecture and gradient composition for osteochondral repair in rabbits.

Authors:  Yingying Du; Haoming Liu; Qin Yang; Shuai Wang; Jianglin Wang; Jun Ma; Insup Noh; Antonios G Mikos; Shengmin Zhang
Journal:  Biomaterials       Date:  2017-05-12       Impact factor: 12.479

3.  Osteogenic differentiation of human bone marrow stromal cells in hydroxyapatite-loaded microsphere-based scaffolds.

Authors:  Nathan H Dormer; Yue Qiu; Anna M Lydick; Nicholas D Allen; Neethu Mohan; Cory J Berkland; Michael S Detamore
Journal:  Tissue Eng Part A       Date:  2011-12-02       Impact factor: 3.845

4.  Integrated bi-layered scaffold for osteochondral tissue engineering.

Authors:  Anna Galperin; Rachael A Oldinski; Stephen J Florczyk; James D Bryers; Miqin Zhang; Buddy D Ratner
Journal:  Adv Healthc Mater       Date:  2012-12-06       Impact factor: 9.933

Review 5.  Three-dimensional osteogenic and chondrogenic systems to model osteochondral physiology and degenerative joint diseases.

Authors:  Peter G Alexander; Riccardo Gottardi; Hang Lin; Thomas P Lozito; Rocky S Tuan
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-03

6.  Catalyst-free synthesis of high elongation degradable polyurethanes containing varying ratios of isosorbide and polycaprolactone: physical properties and biocompatibility.

Authors:  Hyung-seok Park; Myoung-Seon Gong; Jonathan C Knowles
Journal:  J Mater Sci Mater Med       Date:  2012-11-27       Impact factor: 3.896

7.  High-throughput bone and cartilage micropellet manufacture, followed by assembly of micropellets into biphasic osteochondral tissue.

Authors:  Betul Kul Babur; Kathryn Futrega; William B Lott; Travis Jacob Klein; Justin Cooper-White; Michael Robert Doran
Journal:  Cell Tissue Res       Date:  2015-04-30       Impact factor: 5.249

Review 8.  Osteochondral tissue engineering: scaffolds, stem cells and applications.

Authors:  Patcharakamon Nooeaid; Vehid Salih; Justus P Beier; Aldo R Boccaccini
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

9.  Cytocompatibility of the selected calcium phosphate based bone cements: comparative study in human cell culture.

Authors:  Radosław Olkowski; Piotr Kaszczewski; Joanna Czechowska; Dominika Siek; Dawid Pijocha; Aneta Zima; Anna Ślósarczyk; Małgorzata Lewandowska-Szumieł
Journal:  J Mater Sci Mater Med       Date:  2015-10-28       Impact factor: 3.896

Review 10.  Effect of porosities of bilayered porous scaffolds on spontaneous osteochondral repair in cartilage tissue engineering.

Authors:  Zhen Pan; Pingguo Duan; Xiangnan Liu; Huiren Wang; Lu Cao; Yao He; Jian Dong; Jiandong Ding
Journal:  Regen Biomater       Date:  2015-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.